Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,521,594 papers from all fields of science
Search
Sign In
Create Free Account
Poractant alfa 80 MG/ML Intratracheal Suspension [Curosurf]
Known as:
Curosurf 80 MG/ML Intratracheal Suspension
, PORACTANT ALFA 80 mg in 1 mL ENDOTRACHEAL SUSPENSION [Curosurf]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Curosurf
Poractant alfa
Sodium Bicarbonate
Sodium Chloride
Broader (2)
Poractant alfa 80 MG/ML Intratracheal Suspension
Poractant alfa Intratracheal Suspension [Curosurf]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy.
Pieterjan Merckx
,
Lynn De Backer
,
+8 authors
K. Raemdonck
Acta Biomaterialia
2018
Corpus ID: 52032233
2016
2016
Effect of pulmonary surfactant on the dissolution, stability and uptake of zinc oxide nanowires by human respiratory epithelial cells
Ioannis G. Theodorou
,
P. Ruenraroengsak
,
+6 authors
A. Porter
Nanotoxicology
2016
Corpus ID: 38879818
Abstract Inhaled nanoparticles (NPs) have high-deposition rates in the alveolar region of the lung but the effects of pulmonary…
Expand
2015
2015
Silver nanowire interactions with primary human alveolar type-II epithelial cell secretions: contrasting bioreactivity with human alveolar type-I and type-II epithelial cells.
Sinbad Sweeney
,
Ioannis G. Theodorou
,
+9 authors
T. Tetley
Nanoscale
2015
Corpus ID: 26366488
Inhaled nanoparticles have a high deposition rate in the alveolar units of the deep lung. The alveolar epithelium is composed of…
Expand
2013
2013
Internalization of SiO2 nanoparticles by alveolar macrophages and lung epithelial cells and its modulation by the lung surfactant substitute Curosurf®
S. Vranic
,
I. Garcia-Verdugo
,
+5 authors
A. Baeza-Squiban
Environmental science and pollution research…
2013
Corpus ID: 2023529
Because of an increasing exposure to environmental and occupational nanoparticles (NPs), the potential risk of these materials…
Expand
2011
2011
Surfactant and perfluorocarbon aerosolization by means of inhalation catheters for the treatment of respiratory distress syndrome: an in vitro study.
X. Murgia
,
E. Gastiasoro
,
+6 authors
C. Rey-Santano
Journal of Aerosol Medicine
2011
Corpus ID: 26025993
BACKGROUND The aerosolization of perfluorocarbons or surfactant has emerged as a feasible alternative to instillation, for the…
Expand
2011
2011
Interfacial Tensiometry of Tracheal Aspirate from Infants with Neonatal Respiratory Distress Syndrome
A. Jordanova
,
A. Tsanova
,
G. Georgiev
,
D. Chakarov
2011
Corpus ID: 69040030
The interfacial properties of tracheal aspirate from infants with untreated neonatal respiratory distress syndrome (NRDS), and…
Expand
2008
2008
SFP-P044 – Néonatalogie – Dysplasie Alvéolo-Capillaire avec défaut d’alignement des vaisseaux pulmonaires
P. Grué-Fertin
,
I. Arnault
,
S. Méhaut
2008
Corpus ID: 72050652
2005
2005
Curosurf steigert in vivo die Phagozytose apoptotischer neutrophiler Granulozyten durch Alveolarmakrophagen
B. Kramer
,
F. Urlichs
,
S. Seidenspinner
,
C. Speer
2005
Corpus ID: 79555150
2005
2005
7 Combined Treatment with Curosurfá and Beclomethasone in an Elbwi Affected by Severe Chronic Lung Disease
G. Ancora
,
F. Sandri
,
L. Marvulli
,
S. Soffritti
,
G. Faldella
Pediatric Research
2005
Corpus ID: 52865984
Background. Glucocorticoids have been used successfully in the amelioration of chronic lung disease (CLD). Unfortunately, higher…
Expand
1997
1997
Modification de la protéine C réactive après instillation de surfactant exogène naturel (Curosurf
A. Hanache
,
E. Gourrier
,
P. Karoubi
,
S. Merbouche
,
G. Mouchnino
,
J. Leraillez
1997
Corpus ID: 69072212
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE